Identifying and Caring for Individuals With Inherited Cancer Syndrome

ConditionsBRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome Breast Ductal Carcinoma In Situ Hematopoietic and Lymphoid System Neoplasm Hereditary Neoplastic Syndrome Lynch Syndrome Malignant Solid Neoplasm

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorOHSU Knight Cancer Institute

About this trial

This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general public. Researchers hope to learn the value of providing broad, public-wide testing for high risk cancer types (like hereditary breast and ovarian cancer or Lynch syndromes) instead of only testing people whose families are known to be high risk.

Eligibility criteria

Qualifiers

ALL COHORTS: 18 years of age or older

Retrospective COHORT A: Per HIPAA waiver, Retrospective Cohort A will not actively consent

Retrospective COHORT A: Patients may or may not be diagnosed with cancer

Retrospective COHORT A: Patients have received genetic counseling in the past 5 years

Disqualifiers

None

Trial design

Treatments tested in this trial

Biospecimen Collection
Genetic Counseling
Genetic Testing
Survey Administration

Treatment groups

27,500 Participants

are divided into 1 treatment group

Sponsors and collaborators

OHSU Knight Cancer Institute

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Oregon Health and Science University

Collaborator

Source ClinicalTrials.gov